IPR vs. Hatch-Waxman: A C-Suite Guide to Choosing the Right Venue for Your Pharmaceutical Patent Challenge
In the world of pharmaceuticals a patent represents the culmination of a decade or more of painstaking research, countless failed […]
In the world of pharmaceuticals a patent represents the culmination of a decade or more of painstaking research, countless failed […]
A drug patent is more than a legal document; it is the financial bedrock upon which entire companies are built.
Section 1: The Fundamental Question of Patentability for Drug Combinations 1.1 Introduction: Beyond a Simple “Yes” – The Strategic Imperative
Section 1: Introduction: The Value and Paradox of Second Acts in Pharmacology The Rise of Drug Repurposing Drug repurposing, also
The countdown is relentless. For every blockbuster drug that reaches the market, a clock starts ticking, marking the finite years
Beyond the Patent Cliff: 15 Strategies for Pharmaceutical Lifecycle Management Read Post »
In pharmaceutical investing the balance sheet tells you where a company has been. The clinical pipeline tells you where it
How to Predict Drug Stock Performance from Patent Language Read Post »
Part I: Understanding the Terrain: The Unique Landscape of Pharmaceutical Patents The decision to conduct a drug patent search is
The Self-Searcher’s Dilemma: A Comprehensive Guide to Conducting Drug Patent Searches Read Post »
The Core Dilemma: Balancing Innovation Incentives with Public Access At the heart of the pharmaceutical industry lies a fundamental, and
The Double-Edged Sword of Pharmaceutical Patents: A Roadmap for Policy Reform Read Post »
The launch of a biosimilar is not merely a scientific achievement; it is the culmination of a complex, multi-year strategic
Get fresh news and insights, drug patent expirations & more…